ScholarIQanswers from OpenAlex

PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer

PaperCitations, authors & open-access status

PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer have?

ScholarIQcitation count

PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer has 0 citations in the OpenAlex counts ScholarIQ stores.

When was PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer published?

ScholarIQyear

PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer has 2026 year in the ScholarIQ index.

What is the open-access status of PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer?

ScholarIQoa status

PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer has closed oa status in the ScholarIQ index.

What is the DOI of PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer?

ScholarIQdoi

The DOI for PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer is on the source record.

What is the OpenAlex record for PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for PP01.07: Activity of Bevacizumab Combined With Chemotherapy in Advanced RET-Rearranged Non-Small Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial